Anti-desmoglein-1 levels as predictor of prednisolone tapering in pemphigus vulgaris patients treated with rituximab
Author:
Affiliation:
1. Autoimmune Bullous Diseases Research Center; Tehran University of Medical Sciences; Tehran Iran
Publisher
Wiley
Subject
Dermatology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/dth.12671/fullpdf
Reference7 articles.
1. ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus;Abasq;Archives of Dermatology,2009
2. Developing biomarkers for predicting clinical relapse in pemphigus patients treated with rituximab;Albers;Journal of the American Academy of Dermatology,2017
3. Pemphigus, a pathomechanism of acantholysis;Furue;The Australasian Journal of Dermatology,2017
4. First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): A prospective, multicentre, parallel-group, open-label randomised trial;Joly;Lancet,2017
5. B-cell depletion immunotherapy in pemphigus: Effects on cellular and humoral immune responses;Mouquet;The Journal of Investigative Dermatology,2008
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Rituximab in the Management of Autoimmune Bullous Diseases: A Treatment-Resistant Case Series from a Single Central European Referral Center;Medicina;2024-02-04
2. Rituximab - Progress but Still Not a Final Resolution for Pemphigus Patients: Clinical Report From a Single Center Study;Frontiers in Immunology;2022-05-03
3. Long-term experience with rituximab therapy for treatment-resistant moderate-to-severe pemphigus;Journal of Dermatological Treatment;2021-05-22
4. Hematological Inflammatory Markers in Patients with Pemphigus Vulgaris;Dermatology;2021
5. Rituximab in practice: Clinical evaluation of patients with pemphigus after rituximab administration;Dermatologic Therapy;2020-12-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3